We are experts in designing and optimizing miniproteins for therapeutical purposes.
Miniproteins are short peptides stabilized by disulfide bridges and possess highly useful attributes (e.g. stability, solubility, low immunogenicity) and these features are maintained during the directed evolution.
We are experts in designing and optimizing miniproteins for therapeutical purposes.
Miniproteins are short peptides stabilized by disulfide bridges and possess highly useful attributes (e.g. stability, solubility, low immunogenicity) and these features are maintained during the directed evolution.
Our miniprotein based drug discovery platform uses two proprietary technologies leveraging AI-driven scaffold selection combined with state-of-the-art wet lab screening ensuring exceptional selectivity towards any drug target in a lightning-fast discovery process.
Hit validation in 6 months
Radically lower preclinical development costs
AI-powered de novo scaffold selection for any target
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
